Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffold (GABI-R)
German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
Sponsor: Abbott Medical Devices
A observational or N/A phase clinical study on Coronary Artery Stenosis, this trial is completed. The trial is conducted by Abbott Medical Devices and has accumulated 14 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2021 — May 2022 [monthly]
Active Not Recruiting
▶ Show 9 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting
-
Aug 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Mar 2019 — Aug 2020 [monthly]
Active Not Recruiting
-
Dec 2018 — Mar 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2017 — Dec 2017 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jan 2017 — Jul 2017 [monthly]
Active Not Recruiting NA
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
- IHF GmbH - Institut für Herzinfarktforschung
For direct contact, visit the study record on ClinicalTrials.gov .